Cyclophosphamide: An Alternative Treatment in Crohn’s Disease
lmmunosuppressive therapy in the form of 6-mercaptopurine has shown a 66% efficacy in severe, debilitating, highly corticosteroid dependent Crohn’s disease. Nevertheless this medication has some important side effects such as nausea, vomiting, leukopenia and pancreatitis. Two patients are presented...
Saved in:
Main Authors: | Gilles Lapointe, Aubin Charbonneau |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
1989-01-01
|
Series: | Canadian Journal of Gastroenterology |
Online Access: | http://dx.doi.org/10.1155/1989/498156 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cyclophosphamide: An Overview
by: Aditya Kumar Bubna
Published: (2025-01-01) -
New Possibilities for the Treatment of Crohn’s Disease
by: Z. A. Mamieva, et al.
Published: (2019-12-01) -
Cyclophosphamide Pharmacogenomic Variation in Cancer Treatment and Its Effect on Bioactivation and Pharmacokinetics
by: Ibrahim El-Serafi, et al.
Published: (2024-01-01) -
The Role of Inflammation in Crohn’s Disease Recurrence after Surgical Treatment
by: B. Sensi, et al.
Published: (2020-01-01) -
Management of Crohn’s Disease
by: MRB Keighley
Published: (1993-01-01)